Use of Lactulose Breath Tests to Predict Response to Rifaximin in Irritable Bowel Syndrome With Diarrhea: The Positives and Negatives

Am J Gastroenterol. 2020 Jun;115(6):955-956. doi: 10.14309/ajg.0000000000000569.
No abstract available

Publication types

  • Comment

MeSH terms

  • Breath Tests
  • Diarrhea
  • Humans
  • Irritable Bowel Syndrome*
  • Lactulose
  • Rifamycins*
  • Rifaximin

Substances

  • Rifamycins
  • Lactulose
  • Rifaximin